EAS-LatAm webinar: Challenges in achieving control of lipid disorders in LatAm

Atherosclerotic cardiovascular diseases (ASCVD), including myocardial infarction, stroke, and peripheral arterial disease, remain major causes of death in LATAM. The primary strategy for preventing ASCVD involves averting the accumulation of cholesterol-containing atherogenic lipoproteins in the vessel wall. Extensive, well-designed, placebo-controlled studies have demonstrated that lowering LDL cholesterol levels reduces cardiovascular events.

Given the significant number of patients requiring lipid-lowering therapy, a crucial question arises: Are we effectively treating LDL cholesterol levels to attain the desired goals?

In this webinar, we will delve into dyslipidemia as a cardiovascular risk in LATAM. We will discuss LDL cholesterol goals recommended by recent guidelines, focusing on the barriers hindering the achievement of these goals. Moreover, we will emphasize the necessity of identifying the main barriers to getting patients to their goals and controlling cardiovascular risk factors to prevent major cardiovascular events. Additionally, the webinar will explore potential solutions to overcome these challenges.